Back

Non-invasive telemedical interventional management and its cost-effectiveness in patients with heart failure: Economic results of the TIM-HF2 trial

21 May 2022 (08:30 - 18:50)
Organised by:
Congress Presentation Part of: Heart Failure ePosters - focus on Pharmacology and other topics Remote Patient Monitoring and Telehealth HFA Premium Access Heart Failure 2022

About the speaker

Photo
Mrs Hanna Sydow

Charité - University Medicine Berlin, Berlin (Germany)

30 More presentations in this session

Presentation thumbnail
Efficacy and safety of sacubitril/valsartan (LCZ696) in reducing adverse cardiovascular events and controlling hypertension among asians: a meta-analysis of randomised controlled trials
Doctor P. Vera Cruz (Quezon, PH)
Abstract Slides
Presentation thumbnail
Role of empagliflozin in diabetic patient with acute myocardial infarction who undergone percutaneous coronary intervention
Presentation thumbnail
Recovery of left ventricular ejection fraction in patients treated with sacubitril/valsartan
Doctor J. Mesquita Guimaraes (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Levosimendan bridge to therapy optimization
Doctor C. Moliner-Abos (Barcelona, ES)
Abstract Slides
Presentation thumbnail
ORal anti-coagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the ORIGAMI pilot investigation
Doctor D. D'Amario (Novara, IT)
Abstract Slides

Access the full session

Session thumbnail
Heart Failure ePosters - focus on Pharmacology and other topics

The Event

Event poster

Heart Failure 2022

21 May 2022 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources